Clinical Trials Insight: 700034427
Phase of Trial: Phase I
Latest Information Update: 11 Jun 2008
At a glance
- Drugs SL 017 (Primary)
- Indications Actinic keratosis; Skin cancer
- Focus Adverse reactions
- Sponsors Quest PharmaTech
- 11 Jun 2008 New trial record.
- 02 Jun 2008 Results data have been reported in a Quest PharmaTech media release.